Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Self Efficacy
and you are
between 20 and 85
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

We aimed to compare the efficacy of genotypic resistance guided sequential therapy vs. empiric therapy in the third line therapy. Factors affecting the eradication rates, including the antibiotic resistance, CYP2C19 polymorphism, CagA and VacA status will also be assessed.

Provided treatments

  • Drug: empirical therapy
  • Drug: Genotypic resistance guided therapy
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01725906. The sponsor of the trial is National Taiwan University Hospital and it is looking for 450 volunteers for the current phase.
Official trial title:
Genotypic Resistance Guided Therapy in the Treatment of Helicobacter Pylori Infection